| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.48B | +2.4% |
| Cost of Revenue | $2.72B | +2.8% |
| Gross Profit | $762.0M | +0.8% |
| R&D Expense | $105.0M | -6.3% |
| SG&A Expense | $445.0M | +0.7% |
| Operating Income | $254.0M | -1.9% |
| Interest Expense | $81.0M | -18.2% |
| Pre-tax Income | $198.0M | +5.9% |
| Income Tax | $68.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $359.0M | -25.8% |
| Accounts Receivable | $804.0M | -1.6% |
| Inventory | $473.0M | +6.5% |
| Current Assets | $1.76B | -4.3% |
| Total Assets | $3.82B | +1.3% |
| Current Liabilities | $947.0M | -2.3% |
| Long-term Debt | $970.0M | -1.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $312.0M | +1.3% |
| Investing Cash Flow | -$132.0M | -30.7% |
| Financing Cash Flow | -$310.0M | -222.9% |
| -37.0% |
| Net Income | $130.0M | +64.6% |
| EPS (Basic) | $3.31 | +83.9% |
| EPS (Diluted) | $3.24 | +84.1% |
| Total Liabilities |
| $2.23B |
| +1.6% |
| Stockholders' Equity | $1.59B | +0.8% |